Net Loss of Pharmaids Pharmaceuticals reported to Rs 2.48 crore in the quarter ended September 2025 as against net loss of Rs 1.93 crore during the previous quarter ended September 2024. Sales rose 64.31% to Rs 8.61 crore in the quarter ended September 2025 as against Rs 5.24 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales8.615.24 64 OPM %-61.79-45.99 - PBDT-6.18-2.73 -126 PBT-6.65-3.34 -99 NP-2.48-1.93 -28 Powered by Capital Market - Live News

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live News

Pharmaids Pharmaceuticals announced that the 36th Annual General Meeting(AGM) of the company will be held on 23 September 2025.Powered by Capital Market - Live News

Net Loss of Pharmaids Pharmaceuticals reported to Rs 4.95 crore in the quarter ended June 2025 as against net loss of Rs 2.68 crore during the previous quarter ended June 2024. Sales rose 40.80% to Rs 6.66 crore in the quarter ended June 2025 as against Rs 4.73 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales6.664.73 41 OPM %-81.23-71.88 - PBDT-6.56-3.66 -79 PBT-7.17-4.22 -70 NP-4.95-2.68 -85 Powered by Capital Market - Live News

Net Loss of Pharmaids Pharmaceuticals reported to Rs 4.36 crore in the quarter ended June 2025 as against net loss of Rs 1.62 crore during the previous quarter ended June 2024. Sales rose 558.82% to Rs 1.12 crore in the quarter ended June 2025 as against Rs 0.17 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1.120.17 559 OPM %-435.71-1005.88 - PBDT-5.64-1.72 -228 PBT-5.69-1.77 -221 NP-4.36-1.62 -169 Powered by Capital Market - Live News